ギランバレー症候群の世界市場規模、シェア、動向分析：治療別、投与経路別、流通チャネル別、地域別展望と予測（2023年～2030年）

世界のギランバレー症候群の市場規模は、2030年までに8,522億米ドルに達し、予測期間中にCAGR4.6%で成長すると予測されています。

さらに、世界銀行のデータによると、世界銀行の理事会は、アルゼンチンの公的ヘルスケアサービスへのアクセスを改善し、民間医療保険に加入していないブエノスアイレス州の住民650万人に継続的なサービスを保証するために、5,000万米ドルの新たな融資を承認しました。結論として、世界のヘルスケア費の増加が市場の成長を牽引しています。

しかし、GBSの急性期には、入院、集中治療、血漿交換や静脈内免疫グロブリン（IVIG）療法などの専門的な医療介入が必要になることがよくあります。これらの治療には、入院費、薬剤費、医師の診療費など、多額のヘルスケア費がかかる可能性があり、患者とヘルスケア制度に経済的負担がかかります。そのため、治療費の高騰が市場の成長を妨げています。

目次

第1章 市場範囲と調査手法

• 市場の定義
• 目的
• 市場範囲
• セグメンテーション
• 調査手法

第2章 市場要覧

• 主なハイライト

第3章 市場概要

• イントロダクション
  • 概要
    • 市場構成とシナリオ
• 市場に影響を与える主な要因
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の課題
• ポーターのファイブフォース分析

第4章 世界のギランバレー症候群市場：治療別

• 世界の静脈内免疫グロブリン市場：地域別
• 世界の血漿交換市場：地域別
• 世界のその他の市場：地域別

第5章 世界のギランバレー症候群市場：投与経路別

• 世界の非経口市場：地域別
• 世界の経口市場：地域別

第6章 世界のギランバレー症候群市場：流通チャネル別

• 世界の院内薬局市場：地域別
• 世界の小売薬局市場：地域別
• 世界のその他の市場：地域別

第7章 世界のギランバレー症候群市場：地域別

• 北米
  • 北米のギランバレー症候群市場：国別
    • 米国
    • カナダ
    • メキシコ
    • その他北米
• 欧州
  • 欧州のギランバレー症候群市場：国別
    • ドイツ
    • 英国
    • フランス
    • ロシア
    • スペイン
    • イタリア
    • その他欧州
• アジア太平洋
  • アジア太平洋のギランバレー症候群市場：国別
    • 中国
    • 日本
    • インド
    • 韓国
    • シンガポール
    • マレーシア
    • その他アジア太平洋
• ラテンアメリカ・中東・アフリカ
  • ラテンアメリカ・中東・アフリカのギランバレー症候群市場：国別
    • ブラジル
    • アルゼンチン
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ
    • ナイジェリア
    • その他ラテンアメリカ・中東・アフリカ

第8章 企業プロファイル

• F Hoffmann-La Roche Ltd.
• Pfizer, Inc
• PTC, Inc
• AstraZeneca PLC
• Novartis AG
• Novo Nordisk A/S
• Takeda Pharmaceutical Company Limited
• Bayer AG
• Merck & Co, Inc.
• Bristol Myers Squibb Company

第9章 ギランバレー症候群市場の成功必須条件

LIST OF TABLES

• TABLE 1Global Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 2Global Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 3Global Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 4Global Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 5Global Intravenous Immunoglobulin Market by Region, 2019 - 2022, USD Thousands
• TABLE 6Global Intravenous Immunoglobulin Market by Region, 2023 - 2030, USD Thousands
• TABLE 7Global Plasma Exchange Market by Region, 2019 - 2022, USD Thousands
• TABLE 8Global Plasma Exchange Market by Region, 2023 - 2030, USD Thousands
• TABLE 9Global Others Market by Region, 2019 - 2022, USD Thousands
• TABLE 10Global Others Market by Region, 2023 - 2030, USD Thousands
• TABLE 11Global Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 12Global Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 13Global Parenteral Market by Region, 2019 - 2022, USD Thousands
• TABLE 14Global Parenteral Market by Region, 2023 - 2030, USD Thousands
• TABLE 15Global Oral Market by Region, 2019 - 2022, USD Thousands
• TABLE 16Global Oral Market by Region, 2023 - 2030, USD Thousands
• TABLE 17Global Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 18Global Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 19Global Hospital Pharmacies Market by Region, 2019 - 2022, USD Thousands
• TABLE 20Global Hospital Pharmacies Market by Region, 2023 - 2030, USD Thousands
• TABLE 21Global Retail Pharmacies Market by Region, 2019 - 2022, USD Thousands
• TABLE 22Global Retail Pharmacies Market by Region, 2023 - 2030, USD Thousands
• TABLE 23Global Others Market by Region, 2019 - 2022, USD Thousands
• TABLE 24Global Others Market by Region, 2023 - 2030, USD Thousands
• TABLE 25Global Guillain-Barre Syndrome Market by Region, 2019 - 2022, USD Thousands
• TABLE 26Global Guillain-Barre Syndrome Market by Region, 2023 - 2030, USD Thousands
• TABLE 27North America Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 28North America Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 29North America Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 30North America Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 31North America Intravenous Immunoglobulin Market by Country, 2019 - 2022, USD Thousands
• TABLE 32North America Intravenous Immunoglobulin Market by Country, 2023 - 2030, USD Thousands
• TABLE 33North America Plasma Exchange Market by Country, 2019 - 2022, USD Thousands
• TABLE 34North America Plasma Exchange Market by Country, 2023 - 2030, USD Thousands
• TABLE 35North America Others Market by Country, 2019 - 2022, USD Thousands
• TABLE 36North America Others Market by Country, 2023 - 2030, USD Thousands
• TABLE 37North America Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 38North America Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 39North America Parenteral Market by Country, 2019 - 2022, USD Thousands
• TABLE 40North America Parenteral Market by Country, 2023 - 2030, USD Thousands
• TABLE 41North America Oral Market by Country, 2019 - 2022, USD Thousands
• TABLE 42North America Oral Market by Country, 2023 - 2030, USD Thousands
• TABLE 43North America Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 44North America Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 45North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Thousands
• TABLE 46North America Hospital Pharmacies Market by Country, 2023 - 2030, USD Thousands
• TABLE 47North America Retail Pharmacies Market by Country, 2019 - 2022, USD Thousands
• TABLE 48North America Retail Pharmacies Market by Country, 2023 - 2030, USD Thousands
• TABLE 49North America Others Market by Country, 2019 - 2022, USD Thousands
• TABLE 50North America Others Market by Country, 2023 - 2030, USD Thousands
• TABLE 51North America Guillain-Barre Syndrome Market by Country, 2019 - 2022, USD Thousands
• TABLE 52North America Guillain-Barre Syndrome Market by Country, 2023 - 2030, USD Thousands
• TABLE 53US Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 54US Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 55US Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 56US Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 57US Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 58US Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 59US Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 60US Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 61Canada Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 62Canada Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 63Canada Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 64Canada Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 65Canada Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 66Canada Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 67Canada Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 68Canada Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 69Mexico Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 70Mexico Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 71Mexico Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 72Mexico Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 73Mexico Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 74Mexico Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 75Mexico Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 76Mexico Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 77Rest of North America Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 78Rest of North America Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 79Rest of North America Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 80Rest of North America Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 81Rest of North America Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 82Rest of North America Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 83Rest of North America Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 84Rest of North America Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 85Europe Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 86Europe Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 87Europe Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 88Europe Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 89Europe Intravenous Immunoglobulin Market by Country, 2019 - 2022, USD Thousands
• TABLE 90Europe Intravenous Immunoglobulin Market by Country, 2023 - 2030, USD Thousands
• TABLE 91Europe Plasma Exchange Market by Country, 2019 - 2022, USD Thousands
• TABLE 92Europe Plasma Exchange Market by Country, 2023 - 2030, USD Thousands
• TABLE 93Europe Others Market by Country, 2019 - 2022, USD Thousands
• TABLE 94Europe Others Market by Country, 2023 - 2030, USD Thousands
• TABLE 95Europe Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 96Europe Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 97Europe Parenteral Market by Country, 2019 - 2022, USD Thousands
• TABLE 98Europe Parenteral Market by Country, 2023 - 2030, USD Thousands
• TABLE 99Europe Oral Market by Country, 2019 - 2022, USD Thousands
• TABLE 100Europe Oral Market by Country, 2023 - 2030, USD Thousands
• TABLE 101Europe Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 102Europe Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 103Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Thousands
• TABLE 104Europe Hospital Pharmacies Market by Country, 2023 - 2030, USD Thousands
• TABLE 105Europe Retail Pharmacies Market by Country, 2019 - 2022, USD Thousands
• TABLE 106Europe Retail Pharmacies Market by Country, 2023 - 2030, USD Thousands
• TABLE 107Europe Others Market by Country, 2019 - 2022, USD Thousands
• TABLE 108Europe Others Market by Country, 2023 - 2030, USD Thousands
• TABLE 109Europe Guillain-Barre Syndrome Market by Country, 2019 - 2022, USD Thousands
• TABLE 110Europe Guillain-Barre Syndrome Market by Country, 2023 - 2030, USD Thousands
• TABLE 111Germany Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 112Germany Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 113Germany Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 114Germany Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 115Germany Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 116Germany Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 117Germany Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 118Germany Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 119UK Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 120UK Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 121UK Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 122UK Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 123UK Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 124UK Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 125UK Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 126UK Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 127France Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 128France Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 129France Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 130France Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 131France Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 132France Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 133France Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 134France Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 135Russia Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 136Russia Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 137Russia Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 138Russia Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 139Russia Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 140Russia Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 141Russia Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 142Russia Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 143Spain Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 144Spain Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 145Spain Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 146Spain Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 147Spain Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 148Spain Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 149Spain Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 150Spain Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 151Italy Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 152Italy Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 153Italy Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 154Italy Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 155Italy Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 156Italy Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 157Italy Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 158Italy Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 159Rest of Europe Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 160Rest of Europe Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 161Rest of Europe Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 162Rest of Europe Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 163Rest of Europe Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 164Rest of Europe Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 165Rest of Europe Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 166Rest of Europe Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 167Asia Pacific Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 168Asia Pacific Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 169Asia Pacific Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 170Asia Pacific Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 171Asia Pacific Intravenous Immunoglobulin Market by Country, 2019 - 2022, USD Thousands
• TABLE 172Asia Pacific Intravenous Immunoglobulin Market by Country, 2023 - 2030, USD Thousands
• TABLE 173Asia Pacific Plasma Exchange Market by Country, 2019 - 2022, USD Thousands
• TABLE 174Asia Pacific Plasma Exchange Market by Country, 2023 - 2030, USD Thousands
• TABLE 175Asia Pacific Others Market by Country, 2019 - 2022, USD Thousands
• TABLE 176Asia Pacific Others Market by Country, 2023 - 2030, USD Thousands
• TABLE 177Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 178Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 179Asia Pacific Parenteral Market by Country, 2019 - 2022, USD Thousands
• TABLE 180Asia Pacific Parenteral Market by Country, 2023 - 2030, USD Thousands
• TABLE 181Asia Pacific Oral Market by Country, 2019 - 2022, USD Thousands
• TABLE 182Asia Pacific Oral Market by Country, 2023 - 2030, USD Thousands
• TABLE 183Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 184Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 185Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Thousands
• TABLE 186Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2030, USD Thousands
• TABLE 187Asia Pacific Retail Pharmacies Market by Country, 2019 - 2022, USD Thousands
• TABLE 188Asia Pacific Retail Pharmacies Market by Country, 2023 - 2030, USD Thousands
• TABLE 189Asia Pacific Others Market by Country, 2019 - 2022, USD Thousands
• TABLE 190Asia Pacific Others Market by Country, 2023 - 2030, USD Thousands
• TABLE 191Asia Pacific Guillain-Barre Syndrome Market by Country, 2019 - 2022, USD Thousands
• TABLE 192Asia Pacific Guillain-Barre Syndrome Market by Country, 2023 - 2030, USD Thousands
• TABLE 193China Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 194China Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 195China Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 196China Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 197China Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 198China Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 199China Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 200China Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 201Japan Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 202Japan Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 203Japan Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 204Japan Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 205Japan Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 206Japan Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 207Japan Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 208Japan Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 209India Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 210India Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 211India Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 212India Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 213India Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 214India Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 215India Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 216India Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands

• TABLE 217South Korea Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 218South Korea Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 219South Korea Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 220South Korea Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 221South Korea Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 222South Korea Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 223South Korea Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 224South Korea Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 225Singapore Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 226Singapore Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 227Singapore Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 228Singapore Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 229Singapore Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 230Singapore Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 231Singapore Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 232Singapore Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 233Malaysia Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 234Malaysia Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 235Malaysia Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 236Malaysia Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 237Malaysia Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 238Malaysia Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 239Malaysia Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 240Malaysia Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 241Rest of Asia Pacific Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 242Rest of Asia Pacific Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 243Rest of Asia Pacific Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 244Rest of Asia Pacific Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 245Rest of Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 246Rest of Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 247Rest of Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 248Rest of Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 249LAMEA Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 250LAMEA Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 251LAMEA Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 252LAMEA Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 253LAMEA Intravenous Immunoglobulin Market by Country, 2019 - 2022, USD Thousands
• TABLE 254LAMEA Intravenous Immunoglobulin Market by Country, 2023 - 2030, USD Thousands
• TABLE 255LAMEA Plasma Exchange Market by Country, 2019 - 2022, USD Thousands
• TABLE 256LAMEA Plasma Exchange Market by Country, 2023 - 2030, USD Thousands
• TABLE 257LAMEA Others Market by Country, 2019 - 2022, USD Thousands
• TABLE 258LAMEA Others Market by Country, 2023 - 2030, USD Thousands
• TABLE 259LAMEA Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 260LAMEA Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 261LAMEA Parenteral Market by Country, 2019 - 2022, USD Thousands
• TABLE 262LAMEA Parenteral Market by Country, 2023 - 2030, USD Thousands
• TABLE 263LAMEA Oral Market by Country, 2019 - 2022, USD Thousands
• TABLE 264LAMEA Oral Market by Country, 2023 - 2030, USD Thousands
• TABLE 265LAMEA Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 266LAMEA Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 267LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Thousands
• TABLE 268LAMEA Hospital Pharmacies Market by Country, 2023 - 2030, USD Thousands
• TABLE 269LAMEA Retail Pharmacies Market by Country, 2019 - 2022, USD Thousands
• TABLE 270LAMEA Retail Pharmacies Market by Country, 2023 - 2030, USD Thousands
• TABLE 271LAMEA Others Market by Country, 2019 - 2022, USD Thousands
• TABLE 272LAMEA Others Market by Country, 2023 - 2030, USD Thousands
• TABLE 273LAMEA Guillain-Barre Syndrome Market by Country, 2019 - 2022, USD Thousands
• TABLE 274LAMEA Guillain-Barre Syndrome Market by Country, 2023 - 2030, USD Thousands
• TABLE 275Brazil Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 276Brazil Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 277Brazil Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 278Brazil Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 279Brazil Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 280Brazil Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 281Brazil Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 282Brazil Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 283Argentina Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 284Argentina Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 285Argentina Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 286Argentina Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 287Argentina Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 288Argentina Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 289Argentina Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 290Argentina Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 291UAE Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 292UAE Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 293UAE Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 294UAE Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 295UAE Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 296UAE Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 297UAE Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 298UAE Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 299Saudi Arabia Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 300Saudi Arabia Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 301Saudi Arabia Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 302Saudi Arabia Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 303Saudi Arabia Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 304Saudi Arabia Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 305Saudi Arabia Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 306Saudi Arabia Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 307South Africa Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 308South Africa Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 309South Africa Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 310South Africa Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 311South Africa Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 312South Africa Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 313South Africa Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 314South Africa Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 315Nigeria Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 316Nigeria Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 317Nigeria Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 318Nigeria Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 319Nigeria Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 320Nigeria Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 321Nigeria Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 322Nigeria Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 323Rest of LAMEA Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
• TABLE 324Rest of LAMEA Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
• TABLE 325Rest of LAMEA Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
• TABLE 326Rest of LAMEA Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
• TABLE 327Rest of LAMEA Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
• TABLE 328Rest of LAMEA Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
• TABLE 329Rest of LAMEA Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
• TABLE 330Rest of LAMEA Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
• TABLE 331Key Information - F. Hoffmann-La Roche Ltd.
• TABLE 332Key Information - Pfizer, Inc.
• TABLE 333key Information - PTC, Inc.
• TABLE 334KEY INFORMATION - AstraZeneca PLC
• TABLE 335Key Information - Novartis AG
• TABLE 336Key Information - Novo Nordisk A/S
• TABLE 337Key Information - Takeda Pharmaceutical Company Limited
• TABLE 338Key Information - Bayer AG
• TABLE 339Key Information - Merck & Co., Inc.
• TABLE 340Key Information - Bristol Myers Squibb Company

The Global Guillain-Barre Syndrome Market size is expected to reach $852.2 billion by 2030, rising at a market growth of 4.6% CAGR during the forecast period.

North America, particularly the United States and Canada, has a robust healthcare infrastructure with high healthcare spending levels. Thus, the North America segment captured 36.2% revenue share in the market 2022. According to the Government of Canada, since 2014, approximately half of all cases of AFP that have been identified in Canada have been diagnosed with Guillain-Barre syndrome, and approximately twenty percent of those cases have been diagnosed with transverse myelitis.

GBS primarily affects adults, with the highest incidence rates observed in individuals aged 50 and older. As the global population ages, there's a natural increase in the number of people at risk for GBS, which contributes to the rising prevalence of the condition.

Additionally, according to World Bank data, the World Bank Board of Directors approved US$50 million in new financing for Argentina to improve access to public healthcare services and ensure continued service for 6.5 million residents of the province of Buenos Aires without private health insurance. In conclusion, increasing global healthcare expenditures are driving the market's growth.

However, the acute phase of GBS often requires hospitalization, intensive care, and specialized medical interventions such as plasma exchange and intravenous immunoglobulin (IVIG) therapy. These treatments can incur substantial healthcare costs, including hospital charges, medication expenses, and physician fees, placing financial strain on patients and healthcare systems. Thus, the high cost of treatment is impeding the market's growth.

By Therapeutics Analysis

Based on therapeutics, the market is bifurcated into intravenous immunoglobulin, plasma exchange, and others. In 2022, the intravenous immunoglobulin segment garnered 50.9% revenue share in the market. Intravenous immunoglobulin exerts its therapeutic effects through multiple mechanisms, including modulating immune responses.

By Route Of Administration Analysis

On the basis of the route of administration, the market is segmented into parenteral and oral. In 2022, the oral segment attained a noteworthy revenue share in the market. Oral medications are increasingly utilized for early intervention in GBS cases with mild symptoms or as maintenance therapy following the acute phase of the disease.

By Distribution Channel Analysis

Based on distribution channel, the market is categorized into retail pharmacies, hospital pharmacies, and others. In 2022, the hospital pharmacies segment registered 48.8% revenue share in the market. GBS management typically involves a multidisciplinary team of healthcare professionals, including neurologists, intensivists, physiotherapists, and pharmacists, working together to provide comprehensive patient care.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region generated 28.2% revenue share in the market. The diagnostic rate of neurological illnesses, including GBS, has improved in the Asia-Pacific region due to increased public and healthcare professional knowledge.

List of Key Companies Profiled

• F. Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• PTC, Inc.
• AstraZeneca PLC
• Novartis AG
• Novo Nordisk A/S
• Takeda Pharmaceutical Company Limited
• Bayer AG
• Merck & Co., Inc.
• Bristol Myers Squibb Company

Global Guillain-Barre Syndrome Market Report Segmentation

By Therapeutics

• Intravenous Immunoglobulin
• Plasma Exchange
• Others

By Route Of Administration

• Parenteral
• Oral

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

• 1.1Market Definition
• 1.2Objectives
• 1.3Market Scope
• 1.4Segmentation
  • 1.4.1Global Guillain-Barre Syndrome Market, by Therapeutics
  • 1.4.2Global Guillain-Barre Syndrome Market, by Route Of Administration
  • 1.4.3Global Guillain-Barre Syndrome Market, by Distribution Channel
  • 1.4.4Global Guillain-Barre Syndrome Market, by Geography
• 1.5Methodology for the research

Chapter 2.Market at a Glance

• 2.1Key Highlights

Chapter 3.Market Overview

• 3.1Introduction
  • 3.1.1Overview
    • 3.1.1.1Market Composition and Scenario
• 3.2Key Factors Impacting the Market
  • 3.2.1Market Drivers
  • 3.2.2Market Restraints
  • 3.2.3Market Opportunities
  • 3.2.4Market Challenges
• 3.3Porter Five Forces Analysis

Chapter 4.Global Guillain-Barre Syndrome Market by Therapeutics

• 4.1Global Intravenous Immunoglobulin Market by Region
• 4.2Global Plasma Exchange Market by Region
• 4.3Global Others Market by Region

Chapter 5.Global Guillain-Barre Syndrome Market by Route Of Administration

• 5.1Global Parenteral Market by Region
• 5.2Global Oral Market by Region

Chapter 6.Global Guillain-Barre Syndrome Market by Distribution Channel

• 6.1Global Hospital Pharmacies Market by Region
• 6.2Global Retail Pharmacies Market by Region
• 6.3Global Others Market by Region

Chapter 7.Global Guillain-Barre Syndrome Market by Region

• 7.1North America Guillain-Barre Syndrome Market
  • 7.1.1North America Guillain-Barre Syndrome Market by Therapeutics
    • 7.1.1.1North America Intravenous Immunoglobulin Market by Country
    • 7.1.1.2North America Plasma Exchange Market by Country
    • 7.1.1.3North America Others Market by Country
  • 7.1.2North America Guillain-Barre Syndrome Market by Route Of Administration
    • 7.1.2.1North America Parenteral Market by Country
    • 7.1.2.2North America Oral Market by Country
  • 7.1.3North America Guillain-Barre Syndrome Market by Distribution Channel
    • 7.1.3.1North America Hospital Pharmacies Market by Country
    • 7.1.3.2North America Retail Pharmacies Market by Country
    • 7.1.3.3North America Others Market by Country
  • 7.1.4North America Guillain-Barre Syndrome Market by Country
    • 7.1.4.1US Guillain-Barre Syndrome Market
      • 7.1.4.1.1US Guillain-Barre Syndrome Market by Therapeutics
      • 7.1.4.1.2US Guillain-Barre Syndrome Market by Route Of Administration
      • 7.1.4.1.3US Guillain-Barre Syndrome Market by Distribution Channel
    • 7.1.4.2Canada Guillain-Barre Syndrome Market
      • 7.1.4.2.1Canada Guillain-Barre Syndrome Market by Therapeutics
      • 7.1.4.2.2Canada Guillain-Barre Syndrome Market by Route Of Administration
      • 7.1.4.2.3Canada Guillain-Barre Syndrome Market by Distribution Channel
    • 7.1.4.3Mexico Guillain-Barre Syndrome Market
      • 7.1.4.3.1Mexico Guillain-Barre Syndrome Market by Therapeutics
      • 7.1.4.3.2Mexico Guillain-Barre Syndrome Market by Route Of Administration
      • 7.1.4.3.3Mexico Guillain-Barre Syndrome Market by Distribution Channel
    • 7.1.4.4Rest of North America Guillain-Barre Syndrome Market
      • 7.1.4.4.1Rest of North America Guillain-Barre Syndrome Market by Therapeutics
      • 7.1.4.4.2Rest of North America Guillain-Barre Syndrome Market by Route Of Administration
      • 7.1.4.4.3Rest of North America Guillain-Barre Syndrome Market by Distribution Channel
• 7.2Europe Guillain-Barre Syndrome Market
  • 7.2.1Europe Guillain-Barre Syndrome Market by Therapeutics
    • 7.2.1.1Europe Intravenous Immunoglobulin Market by Country
    • 7.2.1.2Europe Plasma Exchange Market by Country
    • 7.2.1.3Europe Others Market by Country
  • 7.2.2Europe Guillain-Barre Syndrome Market by Route Of Administration
    • 7.2.2.1Europe Parenteral Market by Country
    • 7.2.2.2Europe Oral Market by Country
  • 7.2.3Europe Guillain-Barre Syndrome Market by Distribution Channel
    • 7.2.3.1Europe Hospital Pharmacies Market by Country
    • 7.2.3.2Europe Retail Pharmacies Market by Country
    • 7.2.3.3Europe Others Market by Country
  • 7.2.4Europe Guillain-Barre Syndrome Market by Country
    • 7.2.4.1Germany Guillain-Barre Syndrome Market
      • 7.2.4.1.1Germany Guillain-Barre Syndrome Market by Therapeutics
      • 7.2.4.1.2Germany Guillain-Barre Syndrome Market by Route Of Administration
      • 7.2.4.1.3Germany Guillain-Barre Syndrome Market by Distribution Channel
    • 7.2.4.2UK Guillain-Barre Syndrome Market
      • 7.2.4.2.1UK Guillain-Barre Syndrome Market by Therapeutics
      • 7.2.4.2.2UK Guillain-Barre Syndrome Market by Route Of Administration
      • 7.2.4.2.3UK Guillain-Barre Syndrome Market by Distribution Channel
    • 7.2.4.3France Guillain-Barre Syndrome Market
      • 7.2.4.3.1France Guillain-Barre Syndrome Market by Therapeutics
      • 7.2.4.3.2France Guillain-Barre Syndrome Market by Route Of Administration
      • 7.2.4.3.3France Guillain-Barre Syndrome Market by Distribution Channel
    • 7.2.4.4Russia Guillain-Barre Syndrome Market
      • 7.2.4.4.1Russia Guillain-Barre Syndrome Market by Therapeutics
      • 7.2.4.4.2Russia Guillain-Barre Syndrome Market by Route Of Administration
      • 7.2.4.4.3Russia Guillain-Barre Syndrome Market by Distribution Channel
    • 7.2.4.5Spain Guillain-Barre Syndrome Market
      • 7.2.4.5.1Spain Guillain-Barre Syndrome Market by Therapeutics
      • 7.2.4.5.2Spain Guillain-Barre Syndrome Market by Route Of Administration
      • 7.2.4.5.3Spain Guillain-Barre Syndrome Market by Distribution Channel
    • 7.2.4.6Italy Guillain-Barre Syndrome Market
      • 7.2.4.6.1Italy Guillain-Barre Syndrome Market by Therapeutics
      • 7.2.4.6.2Italy Guillain-Barre Syndrome Market by Route Of Administration
      • 7.2.4.6.3Italy Guillain-Barre Syndrome Market by Distribution Channel
    • 7.2.4.7Rest of Europe Guillain-Barre Syndrome Market
      • 7.2.4.7.1Rest of Europe Guillain-Barre Syndrome Market by Therapeutics
      • 7.2.4.7.2Rest of Europe Guillain-Barre Syndrome Market by Route Of Administration
      • 7.2.4.7.3Rest of Europe Guillain-Barre Syndrome Market by Distribution Channel
• 7.3Asia Pacific Guillain-Barre Syndrome Market
  • 7.3.1Asia Pacific Guillain-Barre Syndrome Market by Therapeutics
    • 7.3.1.1Asia Pacific Intravenous Immunoglobulin Market by Country
    • 7.3.1.2Asia Pacific Plasma Exchange Market by Country
    • 7.3.1.3Asia Pacific Others Market by Country
  • 7.3.2Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration
    • 7.3.2.1Asia Pacific Parenteral Market by Country
    • 7.3.2.2Asia Pacific Oral Market by Country
  • 7.3.3Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel
    • 7.3.3.1Asia Pacific Hospital Pharmacies Market by Country
    • 7.3.3.2Asia Pacific Retail Pharmacies Market by Country
    • 7.3.3.3Asia Pacific Others Market by Country
  • 7.3.4Asia Pacific Guillain-Barre Syndrome Market by Country
    • 7.3.4.1China Guillain-Barre Syndrome Market
      • 7.3.4.1.1China Guillain-Barre Syndrome Market by Therapeutics
      • 7.3.4.1.2China Guillain-Barre Syndrome Market by Route Of Administration
      • 7.3.4.1.3China Guillain-Barre Syndrome Market by Distribution Channel
    • 7.3.4.2Japan Guillain-Barre Syndrome Market
      • 7.3.4.2.1Japan Guillain-Barre Syndrome Market by Therapeutics
      • 7.3.4.2.2Japan Guillain-Barre Syndrome Market by Route Of Administration
      • 7.3.4.2.3Japan Guillain-Barre Syndrome Market by Distribution Channel
    • 7.3.4.3India Guillain-Barre Syndrome Market
      • 7.3.4.3.1India Guillain-Barre Syndrome Market by Therapeutics
      • 7.3.4.3.2India Guillain-Barre Syndrome Market by Route Of Administration
      • 7.3.4.3.3India Guillain-Barre Syndrome Market by Distribution Channel
    • 7.3.4.4South Korea Guillain-Barre Syndrome Market
      • 7.3.4.4.1South Korea Guillain-Barre Syndrome Market by Therapeutics
      • 7.3.4.4.2South Korea Guillain-Barre Syndrome Market by Route Of Administration
      • 7.3.4.4.3South Korea Guillain-Barre Syndrome Market by Distribution Channel
    • 7.3.4.5Singapore Guillain-Barre Syndrome Market
      • 7.3.4.5.1Singapore Guillain-Barre Syndrome Market by Therapeutics
      • 7.3.4.5.2Singapore Guillain-Barre Syndrome Market by Route Of Administration
      • 7.3.4.5.3Singapore Guillain-Barre Syndrome Market by Distribution Channel
    • 7.3.4.6Malaysia Guillain-Barre Syndrome Market
      • 7.3.4.6.1Malaysia Guillain-Barre Syndrome Market by Therapeutics
      • 7.3.4.6.2Malaysia Guillain-Barre Syndrome Market by Route Of Administration
      • 7.3.4.6.3Malaysia Guillain-Barre Syndrome Market by Distribution Channel
    • 7.3.4.7Rest of Asia Pacific Guillain-Barre Syndrome Market
      • 7.3.4.7.1Rest of Asia Pacific Guillain-Barre Syndrome Market by Therapeutics
      • 7.3.4.7.2Rest of Asia Pacific Guillain-Barre Syndrome Market by Route Of Administration
      • 7.3.4.7.3Rest of Asia Pacific Guillain-Barre Syndrome Market by Distribution Channel
• 7.4LAMEA Guillain-Barre Syndrome Market
  • 7.4.1LAMEA Guillain-Barre Syndrome Market by Therapeutics
    • 7.4.1.1LAMEA Intravenous Immunoglobulin Market by Country
    • 7.4.1.2LAMEA Plasma Exchange Market by Country
    • 7.4.1.3LAMEA Others Market by Country
  • 7.4.2LAMEA Guillain-Barre Syndrome Market by Route Of Administration
    • 7.4.2.1LAMEA Parenteral Market by Country
    • 7.4.2.2LAMEA Oral Market by Country
  • 7.4.3LAMEA Guillain-Barre Syndrome Market by Distribution Channel
    • 7.4.3.1LAMEA Hospital Pharmacies Market by Country
    • 7.4.3.2LAMEA Retail Pharmacies Market by Country
    • 7.4.3.3LAMEA Others Market by Country
  • 7.4.4LAMEA Guillain-Barre Syndrome Market by Country
    • 7.4.4.1Brazil Guillain-Barre Syndrome Market
      • 7.4.4.1.1Brazil Guillain-Barre Syndrome Market by Therapeutics
      • 7.4.4.1.2Brazil Guillain-Barre Syndrome Market by Route Of Administration
      • 7.4.4.1.3Brazil Guillain-Barre Syndrome Market by Distribution Channel
    • 7.4.4.2Argentina Guillain-Barre Syndrome Market
      • 7.4.4.2.1Argentina Guillain-Barre Syndrome Market by Therapeutics
      • 7.4.4.2.2Argentina Guillain-Barre Syndrome Market by Route Of Administration
      • 7.4.4.2.3Argentina Guillain-Barre Syndrome Market by Distribution Channel
    • 7.4.4.3UAE Guillain-Barre Syndrome Market
      • 7.4.4.3.1UAE Guillain-Barre Syndrome Market by Therapeutics
      • 7.4.4.3.2UAE Guillain-Barre Syndrome Market by Route Of Administration
      • 7.4.4.3.3UAE Guillain-Barre Syndrome Market by Distribution Channel
    • 7.4.4.4Saudi Arabia Guillain-Barre Syndrome Market
      • 7.4.4.4.1Saudi Arabia Guillain-Barre Syndrome Market by Therapeutics
      • 7.4.4.4.2Saudi Arabia Guillain-Barre Syndrome Market by Route Of Administration
      • 7.4.4.4.3Saudi Arabia Guillain-Barre Syndrome Market by Distribution Channel
    • 7.4.4.5South Africa Guillain-Barre Syndrome Market
      • 7.4.4.5.1South Africa Guillain-Barre Syndrome Market by Therapeutics
      • 7.4.4.5.2South Africa Guillain-Barre Syndrome Market by Route Of Administration
      • 7.4.4.5.3South Africa Guillain-Barre Syndrome Market by Distribution Channel
    • 7.4.4.6Nigeria Guillain-Barre Syndrome Market
      • 7.4.4.6.1Nigeria Guillain-Barre Syndrome Market by Therapeutics
      • 7.4.4.6.2Nigeria Guillain-Barre Syndrome Market by Route Of Administration
      • 7.4.4.6.3Nigeria Guillain-Barre Syndrome Market by Distribution Channel
    • 7.4.4.7Rest of LAMEA Guillain-Barre Syndrome Market
      • 7.4.4.7.1Rest of LAMEA Guillain-Barre Syndrome Market by Therapeutics
      • 7.4.4.7.2Rest of LAMEA Guillain-Barre Syndrome Market by Route Of Administration
      • 7.4.4.7.3Rest of LAMEA Guillain-Barre Syndrome Market by Distribution Channel

Chapter 8.Company Profiles

• 8.1F. Hoffmann-La Roche Ltd.
  • 8.1.1Company Overview
  • 8.1.2Financial Analysis
  • 8.1.3Segmental and Regional Analysis
  • 8.1.4Research & Development Expense
  • 8.1.5SWOT Analysis
• 8.2Pfizer, Inc.
  • 8.2.1Company Overview
  • 8.2.2Financial Analysis
  • 8.2.3Regional & Segmental Analysis
  • 8.2.4Research & Development Expense
  • 8.2.5SWOT Analysis
• 8.3PTC, Inc.
  • 8.3.1Company Overview
  • 8.3.2Financial Analysis
  • 8.3.3Segmental and Regional Analysis
  • 8.3.4Research & Development Expenses
  • 8.3.5SWOT Analysis
• 8.4AstraZeneca PLC
  • 8.4.1Company Overview
  • 8.4.2Financial Analysis
  • 8.4.3Regional Analysis
  • 8.4.4Research & Development Expenses
  • 8.4.5SWOT Analysis
• 8.5Novartis AG
  • 8.5.1Company Overview
  • 8.5.2Financial Analysis
  • 8.5.3Segmental and Regional Analysis
  • 8.5.4Research & Development Expense
  • 8.5.5Recent strategies and developments:
    • 8.5.5.1Partnerships, Collaborations, and Agreements:
  • 8.5.6SWOT Analysis
• 8.6Novo Nordisk A/S
  • 8.6.1Company Overview
  • 8.6.2Financial Analysis
  • 8.6.3Segmental and Regional Analysis
  • 8.6.4Research & Development Expenses
  • 8.6.5SWOT Analysis
• 8.7Takeda Pharmaceutical Company Limited
  • 8.7.1Company Overview
  • 8.7.2Financial Analysis
  • 8.7.3Regional Analysis
  • 8.7.4Research & Development Expense
  • 8.7.5SWOT Analysis
• 8.8Bayer AG
  • 8.8.1Company Overview
  • 8.8.2Financial Analysis
  • 8.8.3Segmental and Regional Analysis
  • 8.8.4Research & Development Expense
  • 8.8.5SWOT Analysis
• 8.9Merck & Co., Inc.
  • 8.9.1Company Overview
  • 8.9.2Financial Analysis
  • 8.9.3Segmental and Regional Analysis
  • 8.9.4Research & Development Expenses
  • 8.9.5Recent strategies and developments:
    • 8.9.5.1Partnerships, Collaborations, and Agreements:
  • 8.9.6SWOT Analysis
• 8.10.Bristol Myers Squibb Company
  • 8.10.1Company Overview
  • 8.10.2Financial Analysis
  • 8.10.3Regional Analysis
  • 8.10.4Research & Development Expenses
  • 8.10.5SWOT Analysis

Chapter 9.Winning Imperatives of Guillain-Barre Syndrome Market